Skip to main content
OpenTrials

Clinical trial condition

B-cell Acute Lymphoblastic Leukemia

Explore clinical trials studying B-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

65 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

B-cell Acute Lymphoblastic Leukemia trial results

Active, not recruiting

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

NCT05460533

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Stanford University (Data Collection Only) Stanford, California, United States
  • Children's Hospital Colorado (Data Collection Only) Aurora, Colorado, United States
  • Johns Hopkins University (Data Collection Only) Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

Venetoclax Plus Inotuzumab for B-ALL

NCT05016947

Conditions
ALL, B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, +17 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL

NCT03962465

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Virginia Charlottesville, Virginia, United States
  • VCU Massey Cancer Center Richmond, Virginia, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Completed

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

NCT02435849

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Childrens Hospital Los Angeles SC CTL019 Los Angeles, California, United States
  • Stanford Universtiy Medical Center SC - CTL019B2205J - B2206 Stanford, California, United States
  • Children's Healthcare of Atlanta SC CTL019 Atlanta, Georgia, United States
  • University of Michigan . Ann Arbor, Michigan, United States
View all 23 locations
View Trial Details
Completed

PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies

NCT02730312

Conditions
Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blast Crisis, +39 more
Locations
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
View Trial Details
Completed

Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic Leukaemia

NCT02746952

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Hôpital Saint-Louis Paris, France
View Trial Details

Related conditions